Literature DB >> 15078922

Human immunodeficiency virus (HIV) type 1 Vpu induces the expression of CD40 in endothelial cells and regulates HIV-induced adhesion of B-lymphoma cells.

Winnie W Henderson1, Rebecca Ruhl, Paul Lewis, Matthew Bentley, Jay A Nelson, Ashlee V Moses.   

Abstract

AIDS-related B-cell non-Hodgkin's lymphoma (AIDS-NHL) is a significant cause of morbidity and mortality among individuals infected with human immunodeficiency virus type 1 (HIV-1). AIDS-NHL is clinically and histologically heterogeneous, but common features include an aggressive clinical course and frequent extranodal presentation. HIV-1 infection of nonimmune cells that interact with malignant B cells at extranodal sites may influence both the development and the clinical presentation of disease. Our previous studies have shown that coculture of B-lymphoma (BL) cells with HIV-1-infected endothelial cells (EC) leads to contact activation of EC and firm BL-cell adhesion. The key event promoting EC-BL-cell adhesion was HIV-1 upregulation of endothelial CD40, which allowed induction of vascular cell adhesion molecule 1 (VCAM-1) in a CD40-dependent manner. The present study was designed to identify the HIV-1 protein(s) that influence EC-BL-cell adhesion. When HIV-1 proteins were individually expressed in EC by using recombinant adenoviruses, cultured BL cells adhered exclusively to Vpu-transduced EC. As with HIV-infected EC, adhesive properties were linked to the capacity of Vpu to upregulate CD40, which in turn allowed efficient expression of VCAM-1. When EC were infected with an HIV-1 pseudotype lacking the Vpu gene, CD40 upregulation and BL-cell adhesive properties were lost, indicating an essential role for Vpu in EC-BL-cell interactions. Thus, these data reveal a novel function for HIV-1 Vpu and further suggest a role for Vpu in the development of AIDS-NHL at EC-rich extranodal sites.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15078922      PMCID: PMC387678          DOI: 10.1128/jvi.78.9.4408-4420.2004

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  56 in total

1.  The human immunodeficiency virus type 1 Vpu protein inhibits NF-kappa B activation by interfering with beta TrCP-mediated degradation of Ikappa B.

Authors:  S Bour; C Perrin; H Akari; K Strebel
Journal:  J Biol Chem       Date:  2001-02-16       Impact factor: 5.157

2.  Ligation of CD40 induces the expression of vascular endothelial growth factor by endothelial cells and monocytes and promotes angiogenesis in vivo.

Authors:  M Melter; M E Reinders; M Sho; S Pal; C Geehan; M D Denton; D Mukhopadhyay; D M Briscoe
Journal:  Blood       Date:  2000-12-01       Impact factor: 22.113

3.  B-cell stimulation and prolonged immune deficiency are risk factors for non-Hodgkin's lymphoma in people with AIDS.

Authors:  A E Grulich; X Wan; M G Law; S T Milliken; C R Lewis; R J Garsia; J Gold; R J Finlayson; D A Cooper; J M Kaldor
Journal:  AIDS       Date:  2000-01-28       Impact factor: 4.177

4.  CD154 (CD40L) induces human endothelial cell chemokine production and migration of leukocyte subsets.

Authors:  U Thienel; J Loike; M J Yellin
Journal:  Cell Immunol       Date:  1999-12-15       Impact factor: 4.868

Review 5.  The effects of HIV infection on endothelial function.

Authors:  D Chi; J Henry; J Kelley; R Thorpe; J K Smith; G Krishnaswamy
Journal:  Endothelium       Date:  2000

6.  The human cytomegalovirus chemokine receptor US28 mediates vascular smooth muscle cell migration.

Authors:  D N Streblow; C Soderberg-Naucler; J Vieira; P Smith; E Wakabayashi; F Ruchti; K Mattison; Y Altschuler; J A Nelson
Journal:  Cell       Date:  1999-11-24       Impact factor: 41.582

Review 7.  CD40-CD40L interactions in atherosclerosis.

Authors:  Esther Lutgens; Mat J A P Daemen
Journal:  Trends Cardiovasc Med       Date:  2002-01       Impact factor: 6.677

8.  T cell-mediated signaling to vascular endothelium: induction of cytokines, chemokines, and tissue factor.

Authors:  Claudia Monaco; Evangelos Andreakos; Sylvia Young; Marc Feldmann; Ewa Paleolog
Journal:  J Leukoc Biol       Date:  2002-04       Impact factor: 4.962

Review 9.  Tumor necrosis factor receptor-associated factors (TRAFs).

Authors:  J R Bradley; J S Pober
Journal:  Oncogene       Date:  2001-10-01       Impact factor: 9.867

10.  A novel human WD protein, h-beta TrCp, that interacts with HIV-1 Vpu connects CD4 to the ER degradation pathway through an F-box motif.

Authors:  F Margottin; S P Bour; H Durand; L Selig; S Benichou; V Richard; D Thomas; K Strebel; R Benarous
Journal:  Mol Cell       Date:  1998-03       Impact factor: 17.970

View more
  5 in total

1.  Misdirection of membrane trafficking by HIV-1 Vpu and Nef: Keys to viral virulence and persistence.

Authors:  Andrey Tokarev; John Guatelli
Journal:  Cell Logist       Date:  2011-05

Review 2.  The roles of HIV-1 proteins and antiretroviral drug therapy in HIV-1-associated endothelial dysfunction.

Authors:  Erik R Kline; Roy L Sutliff
Journal:  J Investig Med       Date:  2008-06       Impact factor: 2.895

3.  Cocaine enhances HIV-1 gp120-induced lymphatic endothelial dysfunction in the lung.

Authors:  Xuefeng Zhang; Susan Jiang; Jinlong Yu; Paula M Kuzontkoski; Jerome E Groopman
Journal:  Physiol Rep       Date:  2015-08

Review 4.  Unravelling the Immunomodulatory Effects of Viral Ion Channels, towards the Treatment of Disease.

Authors:  Siobhan Gargan; Nigel J Stevenson
Journal:  Viruses       Date:  2021-10-27       Impact factor: 5.048

Review 5.  Vpu Protein: The Viroporin Encoded by HIV-1.

Authors:  María Eugenia González
Journal:  Viruses       Date:  2015-08-04       Impact factor: 5.048

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.